@GoogleDeepMind: Over the past year, we’ve collaborated with global scientific experts to evaluate the system on complex problems. It as…

X AI KOLs Models

Summary

GoogleDeepMind collaborated with global scientific experts to evaluate an AI system that identified new targets for liver fibrosis and fresh approaches to ALS, digesting decades of research.

Over the past year, we’ve collaborated with global scientific experts to evaluate the system on complex problems. It assisted by: identifying new targets for liver fibrosis, uncovering fresh approaches to tackling Amyotrophic lateral sclerosis (ALS), and digested decades of https://t.co/jhEwy2iwZV
Original Article
View Cached Full Text

Cached at: 06/02/26, 05:34 PM

Over the past year, we’ve collaborated with global scientific experts to evaluate the system on complex problems.

It assisted by: identifying new targets for liver fibrosis, uncovering fresh approaches to tackling Amyotrophic lateral sclerosis (ALS), and digested decades of https://t.co/jhEwy2iwZV

Similar Articles

Uncovering repurposed medicines to fight liver fibrosis

Google DeepMind Blog

DeepMind's Co-Scientist AI helped identify two repurposed medicines that block liver fibrosis in lab tests, including a cancer drug that blocked 91% of a damage response, outperforming human expert selections.

Accelerating discovery of liver disease mechanisms

Google DeepMind Blog

DeepMind's Co-Scientist AI system helped researchers at the University of Edinburgh generate a novel, experimentally verified hypothesis linking the NLRP3 inflammasome to the mechanism of drug resmetirom in MASH liver disease, potentially enabling targeted combination therapies.